Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
10Q coming soon. Very interested to see the narrative.
Sexauer did a good job of representing the company yesterday. Interview was informative and a good synopsis of the projects the company is working on and how they do business. That was also reinforced by PR today which just continues to show the company is focused on being intergated into their customers development process.
That said, the only thing that really will get this company going is results. Looking forward to the 10Q release in a little over a week.
Shoeman is a spammer that has been hammering the FLXT yahoo boards for almost a year. I highly clicking on his profile link and hit ignore.....otherwise you will be stuck seeing his garbage all the time.
Where do you get that information?
If you do your research you will find that Manus is really far along and gaining acceptance quickly.
If you look in the Manus blog, you will see a signature of Flexpoint....a custom designed sensor....or to quote the page "custom flex sensor consisting of two bend areas per finger" (Manus website blog March 15). That means each glove has a 10 pronged sensor.....cool stuff and likely at a nice price point
This could easily become a multi-million dollar revenue source in short order. Add the existing revenues from The toy deal and existing glove companies, the base is getting strong. Also, the next 6 months should have developments with Haemoband, Fortune 100 auto, the robotics toy and new shoe wearable mentioned in the investor presentation and HTK. That doesn't include a potential surprise from Mettis (not counting on it) or Vista Brake. Also, Sexauer continues to being on new uses and users.
A lot of things to be optimistic about.....
Am I missing something? The stock is still down over 30% off its high from mid December even after its gain today. I know the overall market has been in a downspin, but news from Monday seems to make this a much stronger play than it was in mid December. Will be interested to see how the stock performs in the coming days as I was expecting it to jump much higher today given the general market is only down about 10% during the same period and Nasdaq just under 15%.. Only time will tell.
I love how you like to twist things.......
Fact 1.....yes the stock had a million share day after that press release, but only closed at $.20. Previous closes at that point were generally $.17-$.19....so the news did not significantly impact stock price. Also, the following 2 days had less than 151k volume combined.
Fact 2 ...... Rounding to nearest cent, the price range of the stock for the entire month of December was from $.17-$.23. Doesn't sound like the PR had much to do with the PPS of Flexpoint as it was not significantly greater than before it. Also, the November high was greater than the December high.
Fact 3....it was not until January 16 (1 1/2 months later) that the stock cleared the December high of $.23.
Some posters here at the time attributed the rise to rumors that Under Armour was buying 2 companies and Mettis was speculated as possibly 1 of them.
In other words, the PR and the $.35 price were completely unrelated. I don't see much evidence of a company manipulating and fooling the investing public with a PR here. If Mettis was deemed such a game changer when the PR came out, I would think the reaction would be more than a 2 cent gain in share price that day. I think you love to stretch the truth for your own purposes, whatever they may be.....
Lastly, you always talk about insiders dumping stock.......a few things.....the shares created through the debt are restricted shares so they have a hold period (I have not inquired about how long that period is, but I'm guessing it is at least a year)...secondly, insider transactions need to be reported through SEC filings....no filings....no insider transactions.
I do agree that this company will either start showing revenue related to the PRs that have been released or it will fall back into the single digits. I believe that sales are happening and will continue to happen as the company is now marketing and selling to the right customers.
As for Mettis, I have never believed that it was the major driver of this company and my projections have never included much from this product. As for the PR you posted, i believe that was based on the representations of Mr. DeGreef. Given his default on the notes, it wouldn't be hard to believe that the project was postponed because of funding issues or maybe even technology issues with the Bluetooth or the wireless charging. It will be nice if Mettis can be a significant contributor, but I am not counting on it. What I am counting on is auto, toys, gloves and other wearables, and Haemoband. Three of those are confirmed to be moving forward and one still pending. We will only know for sure how things are going when the 10K and Q1 10Q come out.
With that, I'm going to jump off the point counterpoint deal until after Thanksgiving. Happy Thanksgiving to everyone.
You say Mettis has been out for a year, but the first time it was offered for sales was just a few months ago....and they still call it preorders......
Where do you get its been out for a year?
For the record, I have written to the Board Chair and blasted them for the financing methods that they have used as I don't believe that the company would need to pay 10% and give a conversion feature at 36% of the current price.
That said, I believe this October note will be the last as I think that the company will be cash flow positive and self sustaining in the next few months. You spew your hate toward the company and call everything they do misleading.....my opinion is that their only problem is that because of their poor historical funding, they have had a tough time meeting deadlines with their limited resources. My personal projections are the toy deal (I'm estimating 300,000 units) along with gloves, auto, and maybe even Mettis will turn this company cash flow positive in Q1. Of course that's my opinion and I could be wrong....but even if I am, I don't think profits are far away.
In the end I'm guessing the outstanding shares will settle around 85 million. That's more than I like, but not too much that this company can't generate a decent EPS in the future.
So tell me, why are you so interested in bashing this company......you say you would buy if they had proven sales.....so given they don't.....why are you here?
As usual you try to twist things and defame people. First, Sexauer is not a PR guy,he is a sales leader that has a strong track record of driving results. When he says that sales are in the hundreds of thousands annually, that is not something he has made up.....that is coming from his client setting expectations. Since he has been in place which has been just over 4 months, the company has shown new clients and orders and has a new feel to it.
As for Haemoband, the company is real and if you do the homework you will find it is a legitimate company. I checked with some docs that I know here and about half of them were familiar with their product. Also, as I recall, you also stated that Flexpoint only had 1 employee over on the other board, which is far from true.
Look, Flexpoint is far from a perfect company and has its flaws, but is still a bargain for the potential it has to drive significant income IMO. The technology may not be new, but it does appear to be advanced for what it does.
I don't believe that the CEO has been as effective as he could be, but I don't believe him to be dishonest. I believe the PRs that have come out are honest and legitimate. I also believe that you have an agenda of bashing this stock. It's funny how your id creation date coincides with your first 3 posts which were done consecutively in a matter of minutes and not really different from each other (defined as spam under this board's TOU). I welcome good fact filled discussion....just not interested in your defamatory and twisted commentary.
By the way.....did you ever take into account that Mr. Sexauer is an outsider that was hired in to market the product. The PR that is out there recently is primarily coming from Mr. Sexauer and not the regime that you seem to have a problem with and covers projects which he appears to have brought to the table. Based on his history in the industry, I would not think that he would be part of anything as nefarious as you are suggesting.
P.S. My understanding is that Sexauer is a long term shareholder (so he likely has lost money holding the stock) that liked the product so much that he approached Flexpoint. If it was as shady as you portray, I doubt that would have happened.
I'm hopeful the next PR will be on Haemoband which has been dark for a while. I'd like to see completion of phase 4 which would mean a nice progress payment and likelihood of shipments starting first quarter. Of course there could also be new clients hitting the pipe including the relationship built with the company supporting the toy manufacturer.
You can bash all you want... Just like you do on the other message board. We will continue to show different positions and that is fine by me. In the end the only thing that will speak is tangible results and I expect to see that in the not too distant future.
Time will tell Ed. As I said, I don't think it's empty promises. I know if I was looking to do business with the company, I wouldn't have knowing they were in litigation over their IP. Now that the litigation is clear.....I expect that the company wouldn't have something to get in their way.
The technology they have appears to be better than similar type bend products and should make sense for lots of applications including auto because of its lack of issues with moisture and other issues that affect other sensors. I do believe that the 2 major issues (other than lack of capital) were the litigation and the lack of a good marketing strategy. I think both of those issues are fixed and the company is poised to move forward.
You have your opinion and I have mine. I hope you aren't short, because when these deals show in the results, which I believe they will, this stock should skyrocket.
The old investor presentations quoted minimum GPM of 60% so my guess is that it won't take very many wins to make this company profitable. Especially if it has large credible companies as its clients. It also doesn't hurt that a number of clients using the product have won awards including Mimu, Proglove,Veristride, and Mettis.
I agree with you that the past has not been very good for this company....I think that the add of their new VP of Sales, there has been a change and things appear to be more about actual sales and not a project that takes years to come to fruition.
So you are on the sidelines? Or short? If I am right about my assumptions they have waited for the auto company to clear legal.
Many development stage companies rely on capital injections to support them until they become revenue generating. You can chose to believe as you wish, but I believe that Q4 will show more revenue than than any other quarter since the end of the litigation with DeGreef and who knows might even show a break even or a profit, but that will depend on timing of deliveries on the products sold and the amount of development income they received for the preproduction work for the auto maker and maybe the colonoscope. I think the more likely scenario is a small loss for Q4 and profit in Q1 as all of the projects start delivering after their ramp up.
The only thing that will prove either of us right or wrong will be time. By the way, did you lose money as well? Do you own the stock today? Are you long or short or just watching from the sidelines?
I wasn't following Flexpoint at the time, but that was around the same time as the lawsuit with DeGreef. I work with some large companies and their counsel is very sensitive around IP.
My guess is that the field people may have been very happy with the technology and had indicated moving forward. Then the lawyers get involved and see that the IP of the company is clouded by a lawsuit and says that the risks are too great, especially if Flexpoint had lost and DeGreef accused the end user of using the technology without license or consent.
Now that the litigation is done and settled, I think that Flexpoint might finally be back to the point where it can clear the hurdles of large company lawyers reviewing its contracts.
If the actions of Flexpoint were as egregious as you said, why don't I see a class action lawsuit filed by your friends or why is there no record of fines and/or sanctions by the SEC?
Lastly. How much money did your friends lose? Even then it was a penny stock and carried the risks of investing in a penny stock. If they put in all their money because they thought the stock would go up 300% after news that was already released, they were gambling....and unfortunately they lost. Live and learn.
Seems to me that the company hasn't sold many sensors because it has been focused on development work. Looking at recent releases it looks like the company is starting to move from development to product sales as represented by the sales to the major toy company that are estimated to number in the hundreds of thousands annually. The auto industry is a tough one to break into and often does take many years, it appears that they have cleared a hurdle with a major that should open up additional sales.
Other than being late on its time estimates, I don't see this company misrepresenting anything. They've been pretty clear that they are in development with the announcements on the medical, shoe and auto projects. When products are being developed, there are always unexpected things that come up that need fixing or improving. Looks like shoe will start to sell in early 16, and auto will give some development revenue in Q4 and product revenue in 2016. Not sure about the medical as the company hasn't provided any recent updates.
The most recent announcements about new projects seem to be quicker to market, product-based sales. Company is finally moving forward after being stagnant for years. I think 2016 will be a good year for Flexpoint.
PR about auto deal should be good news in the long term. Will be interesting to see how much revenue books to the financials in Q4. Wish it was a different quarter so we wouldn't have to wait 90 days for the results.
Mettis was selected as Honoree in CES Innovation Awards. Should help with the company's credibility going forward.
CES announces its innovation awards tomorrow afternoon. Lots of foreshadowing that Mettis will win the award won by Fitbit 6 years ago......should be good for future prospects for the product.
About a week til the 10Q. Hopefully it has some meaningful updates on the various projects....especially auto horn and colonoscopy. Been way too long since company has said anything relevant on either.
If you haven't looked at the Mettis and Flexpoint websites recently, I highly recommend it. Mettis has a detailed Mettis for Golf section and has added a blog which shows they are up for an award FitBit won 6 years ago which will be announced next week.
Toy company deal should be significant revenue as it projects hundreds of thousands of sensors. Even at the lowest price point should translate to over $1 million in revenue.
Nice midday news showing significant customer for 2016. Company finally starting to show nice progress.
I'm in for just over a year....but bought a lot of it. Been rough watching the value drop 75% from the high. I'm guessing that's nothing compared to you as far as where it is to where you bought.
News shows a positive step forward for the company. Still need to get other things off the ground and move toward self sustainability. Hopeful Q4 will be filled with lots of good news.
I think the key to this stock is getting numerous projects from development to revenue. Mettis is a phenomenal product, but has not been marketed well IMO and will likely take a while to take hold, Haemoband looks to be one that can launch the stock price quickly if the initial annual projections are accurate (at least $10 -20 million revenue based on the 500k to 1MM units listed in filings). Auto still looms and has been given implementation ready status with either Ford or GM (the only 2 fortune 100 auto companies) and can also provide significant revenue. Wearables seems to be a new promising market with FDA approval on the Neofect product that will be launched globally. I just don't know what exactly the company meant when they said these products will bring significant revenue increases (given the revenues are low at this point so any revenue can be viewed as a significant increase).
I think we may actually see a meaningful announcement indicating that one of these projects has taken hold in the next 60-90 days. Once there is some meaningful revenue reported then we should be able to have a better understanding of product margins and how it will translate to the bottom line. My guess is that the gross profit margin is in the 60-80% range and if I'm right, that means very little revenue is needed to cover overhead.
As for projections on price, it's a matter of timing. A number of the key projects have been on the drawing board for years, and the question will be can they be converted to viable selling products. I like the prospects for an announcement on the car horn assembly since it is implementation ready and we should be near the point the auto makers are making decisions for 2017 models. I also think that the last 2 phases of Haemoband will be much shorter than the first 3 and it could be moving forward rapidly. Lastly, it appears that Paul Sexauer is making a difference and that the company is starting to expand its base. That can be key once revenue from one of the projects allows for reinvestment of profits into speeding growth.
I see $.25 - .50 as realistic for year end. If there are announcements on both Haemoband and car horn, I could see the price as high as $2 with the right volume indications. I learned a while ago with this company that things never happen when you think they will so we could be sitting at $.10 as well.
PR this week?
It's been a while since the company has put out a meaningful update. I'm wondering if Paul Sexauer has gained any new customers or forwarded any existing opportunities. Also would be interested to see how Mettis is doing since its launch. Still waiting on updates regarding Haemoband and Auto as well. We should know about all of these things in the near future. Can this company finally lose the title "developmental stage"? Too many potential revenue generators out there.
My guess is the fun will start mid September
Company rewrote options for Mower (and likely its few key employees). Now that they have been taken care of, let the news roll and get this train moving.
I called number on the company website to see if I could get an IR person. The girl that answered the phone said that they did not have IR but asked what my question was. When I asked when fins were to be released, she put me on hold and after a few minutes came back and said there would be a press release soon,but she could not say exactly when. My guess is fins are not near completion. So it might be a while before any real info comes out
Stock seems to have had excessive price decline from what seems to be short term issues. Can't see why this stock took a 20% drop in just a few weeks hitting a 52 week low. Looks like a good time for accumulation.
Volume and price trends have been very positive. Looks like company getting ready for PR soon. I don't think that it is Mettis related either.
My guess is Mettis will be a very long term project and will not be the driving force for FLXT. if you look at last 2 10Q's, the guy behind Mettis is in default on a note to FLXT for $25,000.
I expect that the fruits of hiring Paul Sexauer are starting to blossom and we may see something from left field. Also expect to hear about significant progress on horn switch and Haemoband within the next 60 days. Lastly, a small item on the surface, the SDK (which just recently appeared on the website) should really help the company market to new applications. If I'm reading everything right, Q4 is going to be blast off time for FLXT. JMHO. GLTA.
I bought at .0002......so it's not like I sold at a major loss. Just have a few other pennies that I see better upside in......
Or .05 post split
Better to get $300 instead of the $150 I was planning on
Woohoo....I'm out. My 3 million shares traded today. Glad to say I'm done with this stock. GLTA
Keep in mind the company is at the mercy of auditors that do things at their own pace. Something really minor can add a day or two to a timeframe when you are dealing with bean counters.